Onsite Program - ICNMD 2018
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
ICNMD 2018 July 6 - 10, 2018 | Vienna, Austria › Onsite Program www.icnmd2018.org icnmd2018 #icnmd2018
ww.icnmd2018.org July 6 - 10, 2018 Vienna, Austria
DIAMOND LEVEL
PLATINUM LEVEL
SILVER LEVEL
BRONZE LEVEL
TABLE OF CONTENTS
01 WELCOME MESSAGE 2 PRE-CONGRESS TEACHING COURSES 10
02 COMMITTEES 4 FRIDAY JULY 6, 2018 10
03 PROGRAM AT A GLANCE 6
CONGRESS PROGRAM 14
04 PLENARY SESSIONS 8
SATURDAY JULY 7, 2018 14
05 SPEAKER INFORMATION 9
SUNDAY JULY 8, 2018 17
MONDAY JULY 9, 2018 20
TUESDAY JULY 10, 2018 23
08 CONGRESS INFORMATION 27
FLOORPLAN 28
GENERAL INFORMATION FROM A-Z 30
09 OFFICIAL NETWORKING EVENTS 36
10 POSTER SESSIONS 38
11 INDUSTRY-SUPPORTED SEMINARS 70
12 EXHIBITION INFORMATION 76
15th International Congress on Neuromuscular Diseases WWW.ICNMD2018.ORG 1
01
WELCOME MESSAGE
WELCOME MESSAGE
Message from the ICNMD President
Dear Colleagues,
I am very pleased to invite you to the Interna-
tional Congress on Neuromuscular Diseases
(ICNMD 2018), which will take place in Vienna,
Austria, from July 6 – 10, 2018.
The ICNMD is organized on behalf of the
Applied Research Group on Neuromuscular
Disorders of the World Federation of Neurol-
ogy. Since 2014, the Congress has taken place
Professor Dr. Wolfgang Grisold in two-year cycles. This will be the 15th Inter-
national Congress, following upon previous
› PRESIDENT,
15TH INTERNATIONAL CONGRESS meetings in Nice (2014) and Toronto (2016). Fu-
ON NEUROMUSCULAR DISEASES
ture ICNMD meetings are expected to change
continually between the continents.
The aim of the Congress is to present a wide
spectrum of neuromuscular diseases from the
perspectives of advances in research, diagnosis
and treatment. The main scientific topics will
cover:
• Muscle disease
• Peripheral nerves / Neuropathies
• Neuromuscular junction disorders
• Autonomic system
• Mononeuropathies
• Cranial nerves
• Nerve regeneration
• General diseases and neuromuscular
disorders
• Cancer and the peripheral nervous system
• Patient related topics
• Pain
• History
• Neuromuscular disorders worldwide
• Palliative
2 15th International Congress on Neuromuscular Diseases WWW.ICNMD2018.ORG
01
WELCOME MESSAGE
The format will follow the previous successful
ICNMD meetings and consist of scientific ses-
sions including plenary lectures and scientific
teaching courses, workshop and poster pre-
sentations. The Congress will also offer Virtual
Conferences and of course there will also be
time for attendees to interact and exchange
knowledge and ideas with their esteemed col-
leagues.
The expected aim of the Congress is that the
attendees will gain an updated view on neuro-
muscular disorders and that the networking
opportunities will increase their international
experience and collaborations. The scientific
and program committee have been invited from
all continents around the world to enable this
wide spectrum.
Vienna is an excellent and highly successful
Congress city in Europe, which is easily acces-
sible and provides a rich structure of culture
and ambience serving to foster informal com-
munication.
The Local Organizing Committee along with the
Austrian Society of Neurology and the Ludwig
Boltzmann Institute are delighted to host the
ICNMD 2018 and look forward to meeting you in
Vienna.
Professor Dr. Wolfgang Grisold
ICNMD 2018 Congress President
Ludwig Boltzmann Institute for Experimental
and Clinical Traumatology
Vienna, Austria
15th International Congress on Neuromuscular Diseases WWW.ICNMD2018.ORG 3
02
COMMITTEES
COMMITTEES
PRESIDENT INTERNATIONAL SCIENTIFIC Juan Jesús Vílchez Padilla, Medical
COMMITTEE MEMBERS Research Institute Hospital La Fe,
Spain
Prof. Dr. Wolfgang Grisold, Chongbo Zhao, Huashan Hospital,
Ludwig Boltzmann Institute for Vera Bril, University Health Net- Fudan University, China
Experimental and Clinical Trauma- work University of Toronto, Canada
tology
John England, LSUHSC School of
Vienna, Austria Medicine, USA INTERNATIONAL PROGRAM
COMMITTEE MEMBERS
Marianne de Visser, Academic Med-
ical Centre, The Netherlands
LOCAL COMMITTEE MEMBERS
Eva L. Feldman, University of Mich- Anthony A. Amato, Brigham and
igan, USA Women’s Hospital, Dep. Of Neuro
logy, United States
Friedrich Zimprich, Medical Bruno Giometto, Universita die
University of Vienna, Austria Padova, Italy Corrado Angelini, Foundation San
Camillo Hospital IRCCS, Italy
Wolfgang Löscher, Medical Riadh Gouider, Razi Hospital,
University of Innsbruck, Austria Tunesia Zohar Argov, Hadassah University
Hospital, Israel
Heinz Redl, Ludwig Boltzmann Ryuji Kaji, Tokushima University
Institute for Experimental and Clin- Graduate School of Medicine, Japan Michaela Auer Grumbach, Medical
ical Traumatology, Vienna, Austria University of Vienna, Austria
Satish V. Khadilkar, Bombay Hos-
pital and Medical Research Centre, Richard Barohn, University of
India K ansas Medical Center, United
States
Matthew Kiernan, University of
New South Wales, Australia David Bennett, University of Oxford/
Nuffield Dep. Of Clinical Neurosci-
Jean-Marc Léger, University ences, United Kingdom
Hospital Pitié-Salpêtrièr, France
Günther Bernert, Sozialmedi
Brylev Lev, Moscow City Hospital, zinisches Zentrum Süd –
Russia K aiser-Franz-Josef-Spital mit
Gottfried von Preyer’schem Kinder-
Albert C. Ludolph, Universitäts spital, Austria
klinikum Ulm, Germany
Nazha Birouk, Neurophysiology
Carlos Navarrete Maldonado, Unit, University Hospital Ibn Sina,
Clinica Davila, Chile Rabat, Morocco
Davide Pareyson, Istituto Neuro Saeed A. Bohlega, Saudi Neurology
logico Carlo Besta, Italy Society, Saudi Arabia
Mary Reilly, University College Chiara Briani, University of Padova,
London, UK Dep. Of Neurosciences, Italy
Andreas Steck, University of Basel, Vera Bril, University of Toronto,
Switzerland Canada
Jung-Joon Sung, Seoul National Kristl Claeys, ZU Leuven, Depart-
University Hospital, Korea ment of Neurology, Belgium
4 15th International Congress on Neuromuscular Diseases WWW.ICNMD2018.ORG
02
COMMITTEES
Claude Desnuelle, Centre Hospi- Matthew Kiernan, Univeristy of Luis Querol Gutierrez, Hospital de
talier Universitaire de Nice, France New South Wales, Australia la Santa Creu i Sant Pau, Neuro-
muscular Diseases Unit, Spain
Marianne de Visser, Department Giuseppe Lauria, IRCCS Founda-
of Neurology, Academic Medical tion “Carlo Besta” Neurological Mary Reilly, University College
Centre, The Netherlands Institute, Italy London, United Kingdom
James Dowling, Hospital for Sick Steven Lewis, Rush University James Russell, Univeristy of Mary-
Children (SickKids), Canada Medical Center, USA land School of Medicine, United
States
P. James B. Dyck, Mayo Clinic, Hanns Lochmüller, Institute of
United States Genetic Medicin, Newcastle Uni Gordon Smith, University of Utah,
versity, International Centre for United States
Eva L. Feldman, University of
Life, United Kingdom
Michigan, United States Claudia Sommer, Universitäts
klinikum Würzburg, Neurologische
Albert. C. Ludolph, Universitätsk-
Davis Fursdon, NHS Oxford, UK Klinik und Poliklinik, Germany
linikum Ulm, Germany
Nils E. Gilhus, University of Bergen, Nathan Staff, Mayo Clinic, United
Norway Andrew Mammen, NIAMS/NIH, States
United States
Bruno Giometto, Universita die Volker Straub, Institute of Human
Padova, Italy Michelle L. Mauermann, Mayo Genetics Newcastle, University of
Clinic, United States Newcastle upon Tyne, International
Hans Hilmar Goebel, Universitäts- Centre for Life, United Kingdom
medizin Mainz, Germany Justin McArthur, The Johns
Hopkins Hospital, Dep. Of Neuro Walter Struhal, Kepler Universitäts
Riadh Gouider, Razi Hospital, logy, United States klinikum Linz, Abt. Neurologie 2,
Tunesia Austria
Stefan Meng, University of Vienna,
Wolfgang Grisold, Ludwig Boltz- Center for Anatomy and Cell Biology, Antonio Toscano, University of
mann Institute for Experimental Austria Messina, Italy
und Clinical Traumatology, Austria
Eduardo Nobile Orazio, Humanita Pieter van Doorn, Erasmus MC, Uni-
Thomas Hausner, Lorenz Böhler Research Hospital, Neurology Unit, versity Medical Center Rotterdam,
Hospital, Austria Italy Center for Lysosomal and Metabolic
Diseases,The Netherlands
Max-Josef Hilz, Universitätsklini- David Oliver, University of Kent,
kum Erlangen, Germany United Kingdom Jan Verschuuren, Leiden University
Medical Center, Dep. Of Neurology,
Monika Hofer, Neuropathology and The Netherlands
George W. Padberg, Radboud
Ocular Pathology, Oxford University
University Medical Center, Dep. Of
Hospital, United Kingdom Angela Vincent, University of
Neurology, The Netherlands
Oxford, Nuffield Dep. Of Clinical
Romana Höftberger, Medical Neuroscience, United Kingdom
Davide Pareyson, Istituto Neuro
University of Vienna, Institute of
logicao Carlo Besta, Italy
Neurology, Austria Hugh Willison, University of
Glasgow, Institute of Infection,
Sonja Horn, University of Vienna, Tatjana Paternostro-Sluga,
Ummunity and Inflammation, United
Austria Donauspital Wien, Sozial-
Kingdom
medizisches Zentrum Ost, Austria
Isabel Illa, Hospital santa Creu Anthony J. Windebank, Mayo Clinic,
i Sant Pau (HSCSP), Universitá Amanda C. Peltier, Vanderbilt
United States
Autònoma de Barcelona, Dep. Of University Medical Center, Dep. Of
Neuromuscular Diseases, Spain Neurology, United States Gil I. Wolfe, University of Buffalo,
SUNY, United States
Ryujii Kaji, Tokushima University Alan Pestronk, Washington Uni
Graduate School of Medicine, Dep. versity School of Medicine, Neuro- Chongbo Zhao, Huashan Hospital,
Of Neurology, Japan muscular Clinic, United States Fudan University, China
15th International Congress on Neuromuscular Diseases WWW.ICNMD2018.ORG 5
03 PROGRAM AT A GLANCE
PROGRAM AT A GLANCE
FRIDAY SATURDAY
July 6, 2018 July 7, 2018
7:00
7:30
8:00
8:30
TEACHING COURSES PLENARY SESSION
9:00 1-5 MUSCLE
08:00 - 09:50 08:00 - 10:00
HANDS-ON ULTRASOUND COURSE ON VOLUNTEERS AND ANATOMICAL SPECIMENS
9:30
OFFSITE TEACHING COURSE: ULTRASOUND OF NERVES AND MUSCLES
10:00 NETWORKING BREAK 09:50–10:10
NETWORKING BREAK 10:00 - 10:45
10:30
TEACHING COURSES
11:00 1-5
EUROPEAN FEDERATION OF AUTONOMIC SOCIETIES
10:10 - 12:00 SCIENTIFIC SESSIONS
11:30 10:45 - 12:15
12:00
08:00 - 17:00
NETWORKING BREAK
12:30
(EFAS MEETING 2018)
12:00–13:00
08:00 - 18:30
LUNCH / INDUSTRY-SUPPORTED SEMINARS
13:00 12:15 - 13:45
13:30
TEACHING
EFAS
COURSES
14:00 6-9
SCHOOL
13:00 - 14:50 SCIENTIFIC OVERARCHING
13:00 - 14:50 WORKSHOPS
14:30 13:45 - 15:15
SESSIONS SESSION
13:45 - 15:15 13:45 - 15:15
PATIENT DAY
15:00 NETWORKING BREAK 14:50–15:10
13:00 - 17:00
15:30 NETWORKING BREAK 15:15 - 15:45
TEACHING EFAS
16:00 COURSES SCHOOL
6-9 15:10 - 17:00 SCIENTIFIC
WORKSHOPS
16:30 15:10 - 17:00
15:45 - 17:15
SESSIONS
15:45 - 17:15
17:00
17:30
GUIDED POSTER SESSION
18:00 17:15 - 18:30
18:30
OPENING CEREMONY 18:30 - 19:00
19:00
19:30
OPENING NETWORKING RECEPTION
20:00 19:00 - 21:00
20:30
21:00
21:30
22:00
6 15th International Congress on Neuromuscular Diseases WWW.ICNMD2018.ORG
03
PROGRAM AT A GLANCE
SUNDAY MONDAY TUESDAY
JULY 8, 2018 JULY 9, 2018 JULY 10, 2018
7:00
INDUSTRY-SUPPORTED SEMINARS INDUSTRY-SUPPORTED SEMINARS
07:00 - 08:00 07:00 - 08:00
7:30
8:00
8:30
PLENARY SESSION PLENARY SESSION PLENARY SESSION
NEUROPATHY (Joint ICNMD-PNS) MOTOR NEURONE DISEASE NEUROMUSCULAR JUNCTION 9:00
08:00 - 10:00 08:00 - 10:00 08:00 - 10:00
9:30
10:00
NETWORKING BREAK 10:00 - 10:45 NETWORKING BREAK 10:00 - 10:45 NETWORKING BREAK 10:00 - 10:45
10:30
11:00
SCIENTIFIC SESSIONS SCIENTIFIC SESSIONS SCIENTIFIC SESSIONS
10:45 - 12:15 10:45 - 12:15 10:45 - 12:15 11:30
12:00
12:30
LUNCH / INDUSTRY-SUPPORTED
LUNCH / INDUSTRY-SUPPORTED SEMINARS LUNCH / INDUSTRY-SUPPORTED SEMINARS
12:15 - 13:45 12:15 - 13:45
SEMINARS 13:00
12:15 - 13:45
13:30
14:00
SCIENTIFIC OVERARCHING SCIENTIFIC OVERARCHING SCIENTIFIC
WORKSHOPS WORKSHOPS WORKSHOPS
13:45 - 15:15
SESSIONS SESSION
13:45 - 15:15
SESSIONS SESSION
13:45 - 15:15
SESSIONS 14:30
13:45 - 15:15 13:45 - 15:15 13:45 - 15:15 13:45 - 15:15 13:45 - 15:15
15:00
NETWORKING BREAK 15:15 - 15:45 NETWORKING BREAK 15:15 - 15:45 NETWORKING BREAK 15:15 - 15:45 15:30
WORK-
16:00
SCIENTIFIC ENMC VIRTUAL SCIENTIFIC
SHOPS WORKSHOPS WORKSHOPS SCIENTIFIC
15:45 - 17:15
SESSIONS SYMPOSIUM MEETING
15:45 - 17:15
SESSIONS
15:45 - 17:15 SESSIONS 16:30
15:45 - 17:15 15:45 - 17:15 15:45 – 17:15 15:45 - 17:15
15:45 - 17:15
17:00
CLOSING CEREMONY
17:15 - 18:15 17:30
GUIDED POSTER SESSION GUIDED POSTER SESSION
17:15 - 18:30 17:15 - 18:30 18:00
18:30
19:00
19:30
Industry-Supported Overarching Sessions 20:00
Seminars Networking Breaks Opening / Closing
Workshops Virtual Meeting EFAS 20:30
Plenary Sessions
Guided Poster Session Teaching Courses Patient Day 21:00
Scientific Sessions
21:30
22:00
15th International Congress on Neuromuscular Diseases WWW.ICNMD2018.ORG 7
04 PLENARY SESSIONS
GENERAL CONGRESS INFORMATION
› SATURDAY, JULY 7, 2018 › MONDAY, JULY 9, 2018
08:00 - 10:00 PLENARY SESSION PL 1.0 08:00 - 10:00 PLENARY SESSION PL 3.0
MUSCLE MOTOR NEURONE DISEASE
ROOM: Park Congress 1 - 2 ROOM: Park Congress 1 - 2
› CHAIRS: Wolfgang Grisold, AT & John England, US › CHAIRS: Vera Bril, CA & Claude Desnuelle, FR
08:00 PL 1.1: PATHOMECHANISMS 08:00 PL 3.1: EMERGING THERAPIES FOR MOTOR
› Volker Straub, GB NEURONE DISEASES
› Peter Andersen, SE
08:40 PL 1.2: INFLAMMATORY MECHANISMS
› Andrew Mammen, US 08:40 PL 3.2: CLINICAL CONCEPT OF ALS
› Leonard Van Den Berg, NL
09:20 PL 1.3: GENETICS / EPIGENETICS
› Hanns Lochmüller, DE 09:20 PL 3.3: ETHICAL ISSUES
› David Oliver, GB
› SUNDAY, JULY 8, 2018 › TUESDAY, JULY 10, 2018
08:00 - 10:00 PLENARY SESSION PL 2.0 08:00 - 10:00 PLENARY SESSION PL 4.0
NEUROPATHY NEUROMUSCULAR JUNCTION
ROOM: Park Congress 1 - 2 ROOM: Park Congress 1 - 2
› CHAIRS: Eva Feldman, USA & Mary Reilly, GB › CHAIRS: Julia Wanschitz, AT & Juan Jesús Vílchez
Padilla, ES
08:00 PL 2.1: INHERITED NEUROPATHIES: FROM
GENES TO CLINICAL PHENOTYPE 08:00 PL 4.1: PHYSIOLOGY AND STRUCTURE
› Mary Reilly, GB › Steve Burden, US
08:40 PL 2.2: IMMUNE MEDIATED NEUROPATHIES: 08:40 PL 4.2: CONGENITAL MYASTHENIC SYN-
AN EXPANDING FIELD OF TREATABLE NEU- DROMES - NEW GENES AND BETTER TREAT-
ROPATHIES MENTS / ANTIBODIES
› Pieter Van Doorn, NL › Kinji Ohno, JP
09:20 PL 2.3: ADVANCES IN THE TREATMENT OF
09:20 PL 4.3: AUTOIMMUNITY
PERIPHERAL NEUROPATHY
› David Cornblath, US › Angela Vincent, GB
8 15th International Congress on Neuromuscular Diseases WWW.ICNMD2018.ORG04
05
GENERAL CONGRESS INFORMATION
SPEAKER INFORMATION
SPEAKER READY ROOM
Schnitzler Room on the Mezzanine Floor is the designated Speaker Ready
Room.
OPENING HOURS
THURSDAY, JULY 5 13:00 – 18:00
FRIDAY, JULY 6 07:00 – 18:00
SATURDAY, JULY 7 07:00 – 17:00
SUNDAY, JULY 8 07:00 – 17:00
MONDAY, JULY 9 07:00 – 17:00
TUESDAY, JULY 10 07:00 – 17:00
Important Information for Speakers
If you do not submit your presentation in advance, you are asked to bring it to
the Speaker Ready Room to ensure the quality of your presentation(s) including
fonts, bullets, outlines, animations, etc.
All Presenters (Invited Speakers and Free Communication Session Pre-
senters) are required to submit and/or preview their slides at least 24 hours
prior to their scheduled presentation to ensure compatibility with the Congress
AV Equipment. Priority will be given to speakers who are presenting the next
day.
Technical staff at the Speaker Ready Room will be available to assist with any
audio-visual needs you may have in order to finalise your presentation. A tech-
nical specialist will upload your presentation to a server. Please do not bring
your own laptop or attempt to upload your presentations in your presentation
room.
The organisers cannot guarantee projection of presentation handed in later
than 24 hours prior to the scheduled session.
15th International Congress on Neuromuscular Diseases WWW.ICNMD2018.ORG 906
FRIDAY | JULY 6, 2018
PRE-CONGRESS TEACHING COURSES › FRIDAY JULY 6, 2018
PRE-CONGRESS TEACHING COURSES
All Teaching Course Sessions are located at the Hilton Vienna Am Stadtpark, Austria except
TC 11.0 – ‘Ultrasound of nerves and muscles: Hands-on ultrasound course on volunteers and anatomical
specimens’ which is located at Center for Anatomy and Cell Biology, Medical University of Vienna,
Austria (Off-site)
8:00 - 12:00 TC 1.0 - HyperCKemia 09:50 NETWORKING BREAK
ROOM Park Congress 1 10:10 TC 2.3: PRESYNAPTIC RECEPTORS AND
NEUROMUSCULAR TRANSMISSION
Chairs: Corrado Angelini, IT & Marianne De Ana Sebastião, PT
Visser, NL
11:05 TC 2.4: DISEASES INVOLVING
08:00 TC 1.1: CLINICAL PHENOTYPES AND IMPAIRMENT AND LOSS OF
HOW TO MANAGE PATIENTS WITH HIGH NEUROMUSCULAR CONNECTIONS
HYPERCKEMIA, STATIN MYOPATHY Hanns Lochmüller, DE
Marianne De Visser, NL
8:00 - 12:00 TC 3.0 - Didactic TC on genetic
08:55 TC 1.2: HOW TO DIAGNOSE A PATIENT
neuropathies
WITH HYPERCKEMIA
Sabrina Sacconi, FR ROOM Park Congress 3
Chairs: Michaela Auer-Grumbach, AT &
09:50 NETWORKING BREAK Davide Pareyson, IT
10:10 TC 1.3: HYPERCKEMIA IN MUSCULAR 08:00 TC 3.1: CMT NEUROPATHIES IN THE
DISTROPHIES AND METABOLIC ELDERLY
MYOPATHIES Michaela Auer-Grumbach, AT
Corrado Angelini, IT
08:55 TC 3.2: ESSENTIAL CLUES TO
11:05 TC 1.4: DIAGNOSTIC APPROACH AND EARLY RECOGNITION OF AMYLOID
GUIDELINES FOR OLIGOSYMPTOMATIC NEUROPATHIES
HYPERCKEMIA Davide Pareyson, IT
Theodore Kyriakides, CY
09:50 NETWORKING BREAK
8:00 - 12:00 TC 2.0 - "Basic Course":
Neuromuscular structure, 10:10 TC 3.3: SENSORY AND AUTONOMIC
HEREDITARY NEUROPATHIES
transmission and the diseases that Max Hilz, DE
affect it
ROOM Park Congress 2 11:05–12:00 TC 3.4: NEUROPATHIC MANIFESTATIONS
IN PORPHYRIA
Chairs: William Phillips, AU & Hanns P. James Dyck, US
Lochmüller, DE
8:00 - 12:00 TC 4.0 - Floppy infant syndrome:
08:00 TC 2.1: INTRODUCTION TO STRUCTURE clinical assessment and decisions
& FUNCTION, MECHANISMS OF NMJ ROOM Klimt 1
DEVELOPMENT AND EFFECTS OF
AUTOANTIBODIES Chairs: Gunther Bernert, AT & James
William Phillips, AU Dowling, CA
08:55 TC 2.2: NEUROPHYSIOLOGY 08:00 TC 4.1: EPIDEMIOLOGY AND
Clarke Slater, GB
DIFFERENTIAL DIAGNOSIS
Guenther Bernert, AT
10 15th International Congress on Neuromuscular Diseases WWW.ICNMD2018.ORG08:55 TC 4.2: CLINICAL ASSESSMENT AND 15:10 TC 6.3: GENETIC APPROACH TO MUSCLE
MUSCLE IMAGING: TECHNIQUES AND DISORDERS
PITFALLS Tahseen Mozaffar, US 06
Eugenio Mercuri, IT
16:05 TC 6.4: APPROACH TO TRANSLATIONAL
RESEARCH AND CLINICAL TRIALS IN
FRIDAY | JULY 6, 2018
09:50 NETWORKING BREAK MUSCLE DISEASE
Michael Hanna, GB
10:10 TC 4.3: FLOPPY INFANT SYNDROME AND
THE ROLE OF “NEXT GEN”
James Dowling, CA
13:00–17:00 TC 7.0 - Diagnostics and treatment of
11:05 TC 4.4: WHAT YOU MAY MISS WITHOUT ALS and MND
EMG
Matthew Pitt, GB ROOM Zweig
Chairs: Albert Ludolph, DE & Dorothée
Lulé, DE
PRE-CONGRESS TEACHING COURSES
8:00 - 12:00 TC 5.0 - Electrodiagnostic and 13:00 TC 7.1: HOW DO WE DISCUSS THE
sonographic evaluation of entrapment GENETIC IMPLICATIONS WITH ALS
mononeuropathies (Hands-On) Ryuji Kaji, JP
ROOM Berg
13:55 TC 7.2: COGNITIVE CHANGE –
Machine in-kind donation by RECOGNITION AND MANAGEMENT
Albert Ludolph, DE
14:50 NETWORKING BREAK
Note: There is a variety of different similar
products that can be used beyond the ones 15:10 TC 7.3: BREAKING THE NEWS OF THE
showcased in this session. DIAGNOSIS
Dorothée Lulé, DE
Chairs: Wolfgang Löscher, AT & Nens Van
Alfen, NL 16:05–17:00 TC 7.4: THE ROLE OF MULTIDISCIPLINARY
CARE IN ALS
08:00 TC 5.1: ENTRAPMENT SYNDROMES Christopher McDermott, US
IN THE UPPER EXTREMITY –
ELECTROPHYSIOLOGY 13:00–17:00 TC 8.0 - New way to diagnose and
Christian Bischoff, DE assess neuropathies
ROOM Park Congress 2
08:55 TC 5.2: ENTRAPMENT SYNDROMES IN
THE UPPER EXTREMITY – SONOGRAPHY Chairs: Peter Van Den Bergh, BE & Ingemar
Nens Van Alfen, NL Merkies, NL
09:50 NETWORKING BREAK 13:00 TC 8.1: MRI AND US IN THE DIAGNOSIS OF
NEUROPATHY
10:10 TC 5.3: ENTRAPMENT SYNDROMES Stephan Goedee, NL
IN THE LOWER EXTREMITY – 13:55 TC 8.2: SKIN BIOPSY: NOT JUST FOR
ELECTROPHYSIOLOGY DIAGNOSIS
Simon Podnar, SI Grazia Devigili, IT
11:05 TC 5.4: ENTRAPMENT SYNDROMES IN
THE LOWER EXTREMITY 14:50 NETWORKING BREAK
Alexander Grimm, DE 15:10 TC 8.3: OUTCOME MEASURES IN
NEUROPATHY
12:00–13:00 NETWORKING BREAK Ingemar Merkies, NL
ROOM Bruckner - Strauss & Klimt 2 - 3
16:05 TC 8.4: ROLE OF ELECTROPHYSIOLOGY
IN THE CHARACTERIZATION AND
DIAGNOSIS OF NEUROPATHIES: NEW
13:00–17:00 TC 6.0 - Clinical: from pattern INSIGHTS
recognition towards clinical diagnosis Peter Van den Bergh, BE
ROOM Berg
13:00–17:00 TC 9.0 - Understanding the drug
Chairs: Richard Barohn, US & Mazen development process for rare
Dimachkie, US neuromuscular diseases
ROOM Klimt 1
13:00 TC 6.1: A PATTERN RECOGNITION
APPROACH TO PATIENTS WITH A Chairs: Volker Straub, GB & Kanneboyina
SUSPECTED MYOPATHY Nagaraju, US & Raffaella Willmann, CH
Richard Barohn, US 13:00 Introduction
13:55 TC 6.2: LABORATORY APPROACH TO Volker Straub
MUSCLE DISORDERS
Mazen Dimachkie, US Session 1: Drug design
13:10 TC 9.1: REQUIREMENTS AND PITFALLS
14:50 NETWORKING BREAK FOR SMALL MOLECULES
Mike Kelly, US
15th International Congress on Neuromuscular Diseases WWW.ICNMD2018.ORG 1106
FRIDAY | JULY 6, 2018
PRE-CONGRESS TEACHING COURSES
13:20 TC 9.2: REQUIREMENTS AND PITFALLS 13:40 TC 10.3: CARDIOVASCULAR AUTONOMIC
FOR GENE THERAPY FUNCTION TESTS AND ABPM
Isabelle Richard, FR Giovanna Calandra-Buonaura, IT
13:30 TC 9.3: REQUIREMENTS AND PITFALLS
FOR STEM CELLS 14:00 TC 10.4: NEUROENDOCRINE AND
Miranda Grounds, AU NUCLEAR AUTONOMIC FUNCTION TESTS
Camilla Rocchi, IT
Session 2: Preclinical efficacy data
14:20 TC 10.5: PRACTICAL SESSION: HOW
13:40 TC 9.4: PRECLINICAL TRIAL DESIGN TO PERFORM A CARDIOVASCULAR
Annamaria De Luca, IT AUTONOMIC FUNCTION TEST, PART I
13:50 TC 9.5: STATISTICAL POWER EVALUATION Walter Struhal, AT
Heather Gordish-Dressman, US
14:50 NETWORKING BREAK
14:00 TC 9.6: DATA INTERPRETATION,
TRANSLATIONAL MEANING
Annamaria De Luca, IT 15:10 TC 10.6: AUTONOMIC HISTORY TAKING:
YOU NEED TO KNOW WHAT YOU’RE
Session 3: Clinical trial design LOOKING FOR
Roland Thijs, NL
14:10 TC 9.7: REGULATORY REQUIREMENTS
Didier Caizergues, FR 15:30 TC 10.7: SYNCOPE, PSEUDOSYNCOPE
AND OTHER ORTHOSTATIC INTOLERANCE
14:20 TC 9.8: CLINICAL TRIAL READINESS SYNDROMES
Kathryn Wagner, US Anne Pavy-Le Traon, FR
14:30 TC 9.9: CARE ASPECTS IN CLINICAL TRIAL 15:50 TC 10.8: AUTONOMIC SYNDROMES: HOW
PLANNING TO PUT THE PIECES OF THE JIGSAW
Anna Mayhew, GB TOGETHER
14:40 TC 9.10: PATIENT PERSPECTIVE Eva Lenzenweger, AT
Elizabeth Vroom, NL 16:10 TC 10.9: SYNCOPE AND PSEUDOSYNCOPE
14:50 TC 9.11: BUSINESS MODEL J. Gert Van Dijk, NL
Cristina Csimma, US 16:30 TC 10.10: EBM TREATMENT OF
ORTHOSTATIC HYPOTENSION AND
15:00 NETWORKING BREAK RELATED SYMPTOMS
Gregor K. Wenning, AT
15:30 TC 9.12: PLENARY SESSION: THE TACT
PROCEDURE BY MEANS OF A MOCK TACT 16:50 TC 10.11: EVALUATION FORMS AND
APPLICATION CONCLUDING REMARKS
16:30 QUESTION & ANSWER 08:00–17:00 TC 11.0 - ULTRASOUND OF NERVES
AND MUSCLES HANDS-ON ULTRASOUND
13:00–17:00 TC 10.0 - EFAS School: Bed side COURSE ON VOLUNTEERS AND
management and testing for clinical ANATOMICAL SPECIMENS
autonomic disorders
ROOM Park Congress 3 LOCATION CENTER FOR ANATOMY
AND CELL BIOLOGY, MEDICAL UNI-
Chairs: Walter Struhal, AT & Anne Pavy-Le VERSITY OF VIENNA, AUSTRIA (OFF-SITE)
Traon, FR
Machine in-kind donation by
13:00 TC 10.1: ANS: THE INTERFACE BETWEEN
OUTER AND INNER WORLD
Isabel Rocha, PT
Note: There is a variety of different similar
13:20 TC 10.2: AUTONOMIC DISORDERS: WHAT products that can be used beyond the ones
GOES WRONG showcased in this session
Heinz Lahrmann, AT
Chair: Stefan Meng, AT
12 15th International Congress on Neuromuscular Diseases WWW.ICNMD2018.ORG06
FRIDAY | JULY 6, 2018
PRE-CONGRESS TEACHING COURSES
08:00 WELCOME AND BASIC ANATOMY AND 15:20 - 15:40 "DIE EINGESCHLAFENE HAND“
INTERVENTION TACTICS Elisabeth Lindeck-Pozza, AT
Stefan Meng, AT & Daniel Truong, US
15:40 - 16:00 ERKRANKUNGEN DES
08:30 NERVE PART 1.1: HANDS-ON NEUROMUSKULAREN UBERGANGES
ULTRASOUND ASSESSMENT OF LOCAL, (MYASTHENIA GRAVIS)
PERINEURAL ANATOMY Raffi Topakian, AT
Stefan Meng, AT
16:00 - 16:20 AMYOTROPHE LATERAL SKLEROSE (ALS)
09:45 NERVE PART 1.2: ULTRASOUND GUIDED Heinz Lahrmann, AT
INJECTIONS IN ANATOMIC SPECIMEN
16:20-16:40 ERKRANKUNGEN DES AUTONOMEN
Stefan Meng, AT
NERVENSYSTEMS
Walter Struhal, AUT
11:00 NETWORKING BREAK
11:30 MUSCLE: PRACTICAL MUSCLE
BOTULINUM TOXIN INJECTION COURSE 18:30 - 21:00 OPENING CEREMONY
Daniel Truong, US ROOM PARK CONGRESS 1 – 2
WELCOME RECEPTION
14:30 NETWORKING BREAK
ROOM EXHIBITION &POSTERS AREA
15:00 NERVE PART 2.1: INSPECTIONS OF
PREPARED SPECIMENS FROM NERVE
PART 1: ANATOMICAL TOPOLOGY,
INJECTION FLUID DISTRIBUTION
Stefan Meng, AT
16:30 NERVE PART 2.2: NEW NERVE
ULTRASOUND INJECTIONS IN ANATOMIC
SPECIMEN
13:00–17:00 Public Patient Day
ROOM Park Congress 1
Chair: Wolfgang Grisold, AT
13.10 - 13.30 AUS DER SICHT DES PATIENTEN:
ERKRANKUNGEN DES
NEUROMUSKULAREN ÜBERGANGES
(MYASTHENIA GRAVIS)
Evelyn Suritsch, AT
13.30 - 13.50 MUSKELERKRANKUNGEN BEI KINDERN,
NEUE THERAPIEN
Guenther Bernert, AT
13:50 - 14:10 MUSKELERKRANKUNGEN BEI
ERWACHSENEN
Julia Wanschitz, AT
14:10 - 14:30 POLYNEUROPATHIEN
Wolfgang Löscher, AT
15:00 - 15:20 POLYNEUROPATHIEN - FOKUS DIABETES
MELLITUS
Eva Feldman, USA
15th International Congress on Neuromuscular Diseases WWW.ICNMD2018.ORG 1307 CONGRESS PROGRAM › SATURDAY JULY 7, 2018
SATURDAY | JULY 7, 2018
07:00 -18:30 EFAS ANNUAL MEETING 2018 Scientific Session II:
ROOM Park Congress 3
12:00 SS 6: AUTONOMIC DYSFUNCTION IN THE
INITIAL MOTOR STAGE OF PARKINSON’S
Plenary Session I) Peripheral autonomic DISEASE: A 3-YEAR LONGITUDINAL
STUDY
neuropathies
Iva Stankovic, RS
08:00 PL 1: DIABETIC AUTONOMIC
NEUROPATHY 12:05 SS 7: ACQUIRED IDIOPATHIC
Roy Freeman, US GENERALIZED ANHIDROSIS IN A YOUNG
AUSTRIAN PATIENT
08:30 PL 2: AUTONOMIC DYSFUNCTION IN GBS Gerald Exler, AT
Max Hilz, DE
12:10 NETWORKING BREAK
08:50 PL 3: ANS AND AMYLOID
Isabel Rocha, PT
12:55 GUIDED POSTER WALK
Scientific Session I
09:10 SS 1: AUTOIMMUNE AUTONOMIC Plenary Session III) TLOC, Brain injury and ANS
GANGLIONOPATHY: THE NATIONAL
sequelae
HOSPITAL FOR NEUROLOGY AND
NEUROSURGERY, QUEEN SQUARE 13:45 PL 8: DIFFERENTIAL DIAGNOSIS
EXPERIENCE J. Gert Van Dijk, NL
Shiwen Koay, GB
14:05 PL 9: AUTONOMIC DYSFUNCTION IN
09:20 SS 2: MICRONEUROGRAPHIC EVIDENCE EPILEPSY
AGAINST BAROREFLEX BLUNTING WITH Roland Thijs, NL
PERIPHERAL CHEMOREFLEX ACTIVATION
IN HUMANS 14:25 PL 10: STROKE AND ANS
Karsten Heusser, DE Max Hilz, DE
09:30 SS 3: THE NATURAL HISTORY OF A 14:45 PL 11: SYNCOPEDIA: TRAINING A NEW
COHORT OF ISOLATED AUTONOMIC GENERATION OF SYNCOPE SPECIALISTS
FAILURE PATIENTS Jelle De Jong, NL
Pietro Guaraldi, IT
09:35 SS 4: ORTHOSTATIC HYPERTENSION: A Scientific Session III:
RARE KNOWN DYSAUTONOMIA
15:05 SS 8: MUTUALLY EXCLUSIVE CRITERIA
Alvaro Petersen, MX
FOR NEUROGENIC ORTHOSTATIC
09:40 SS 5: HOW TO OVERCOME POST- HYPOTENSION AND VASOVAGAL
OPERATIVE ILEUS IN PERITONITS SYNCOPE DURING TILT-TABLE TESTING
PATIENS Maryam Ghariq, NL
Peter Lechner, AT
15:10 SS 9: HEART RATE VARIABILITY IS
ASSOCIATED WITH OUTCOME IN
09:50 NETWORKING BREAK
SPONTANEOUS INTRACEREBRAL
HEMORRHAGE
Marek Sykora, AT
Plenary Session II) Neurodegeneration & ANS
10:40 PL 4: PAF-MSA-PARKINSON HOW TO 15:15 NETWORKING BREAK
DIFFERENTIATE, HOW TO CONFUSE,
SIMILARITIES AND SPECIFICS
Gregor K. Wenning, AT Plenary Session IV) Autonomic Nervous system and
Fatigue Background and Management
11:00 PL 5: LINKS FROM PERIPHERY TO THE
BRAIN 15:45 PL 12: AUTONOMIC NERVOUS
Alessandra Fanciulli, AT SYSTEM IN SIMULATED AND REAL
11:20 PL 6: SLEEP DISORDERS & ANS WEIGHTLESSNESS
Pietro Guaraldi, IT Anne Pavy-Le Traon, FR
11:40 PL 7: AUTONOMIC DYSFUNCTION IN 16:05 PL 13: PROGNOSTIC AUTONOMIC
DEMENTIA BIOMARKERS
Walter Struhal, AT Jean-Michel Senard, FR
14 15th International Congress on Neuromuscular Diseases WWW.ICNMD2018.ORG16:25 PL 14: FATIGUE AND AUTONOMIC 11:45 SS 2.3: NEW DEVELOPMENTS IN
NERVOUS SYSTEM DYSFUNCTION IN CONDUITS
PEOPLE WITH MULTIPLE SCLEROSIS David Hercher, AT 07
Mario Habek, HR
SATURDAY | JULY 7, 2018
16:45 PL 15: GASTRIC DYSFUNCTION 10:45 - 12:15 Scientific Session SS 3.0 Paraneoplastic
Heinz Zoller, AT neuromuscular aspects
ROOM Park Congress 2
Scientific Session IV:
Chairs: Bruno Giometto, IT & Andrew
17:05 SS 10: UROFLOWMETRY SHOWS Mammen, US
SLIGHTLY IMPAIRED AUTONOMIC
BLADDER FUNCTION IN PATIENTS WITH 10:45 SS 3.1: THE ROLE OF HU PROTEINS IN THE
RELAPSING-REMITTING MULTIPLE DEVELOPMENT OF PARANEOPLASTIC
SCLEROSIS NEUROPATHIES
Ruihao Wang, DE Bruno Giometto, IT
17:15 CLOSING REMARKS AND POSTER PRIZE
11:07 SS 3.2: PHYSIOPATHOLOGY OF
PARANEOPLASTIC GANGLIONOPATHIES
Romana Hoeftberger, AT
8:00 - 10:00 Plenary Session PL 1.0 Muscle
ROOM Park Congress 1 - 2 11:29 SS 3.3: PARANEOPLASTIC MUSCLE
DISORDERS
Chairs: Wolfgang Grisold, AT & John
Andrew Mammen, US
England, US
08:00 PL 1.1: PATHOMECHANISMS 11:51 SS 3.4: LAMBERT-EATON-SYNDROME
Volker Straub, GB (LEMS)
Jan Verschuuren, NL
08:40 PL 1.2: INFLAMMATORY MECHANISMS
Andrew Mammen, US 12:15 - 13:45 LUNCH / INDUSTRY-SUPPORTED
SEMINARS
09:20 PL 1.3: GENETICS / EPIGENETICS
Hanns Lochmüller, DE ROOMS PARK CONGRESS 1 / 2
10:00 - 10:45 NETWORKING BREAK
ROOM Bruckner - Strauss & Klimt 2 - 3 13:45 - 15:15 Scientific Session SS 4.0
New clinical entities
ROOM Park Congress 1
10:45 - 12:15 Scientific Session SS 1.0 New therapies
ROOM Park Congress 1 Chairs: Antonio Toscano, IT & Bjarne Udd, FI
Chairs: Marianne De Visser, NL &
13:45 SS 4.1: UPDATE ON CLINICAL ASPECTS OF
Kanneboyina Nagaraju, US
GLYCOGEN STORAGE DISORDERS
10:45 SS 1.1: TREATMENT STRATEGIES IN GNE Antonio Toscano, IT
MYOPATHY
Zohar Argov, IL 14:15 SS 4.2: NOVEL ENTITIES IN CONGENITAL
MYOPATHIES OF ADULT ONSET
11:15 SS 1.2: UPDATE OF RNA-BASED NMD Baziel Van Engelen, NL
THERAPIES
Kanneboyina Nagaraju, US 14:45 SS 4.3: NEW PHENOTYPES IN TITIN
11:45 SS 1.3: PROGRESS IN THE TREATMENT DEFECTS
OF IDIOPATHIC INFLAMMATORY Bjarne Udd, FI
MYOPATHIES?
Marianne De Visser, NL 13:45 - 15:15 Workshops WS 1.0
Iatrogenic nerve lesions
10:45 - 12:15 Scientific Session SS 2.0 Nerve ROOM Klimt 1
Regeneration
ROOM Klimt 1 Chairs: Tatjana Paternostro-Sluga, AT &
Anthony Windebank, US
Chairs: Anthony Windebank, US & Heinz
Redl, AT 13:45 WS 1.1: CHEMOTHERAPY INDUCED PNP
10:45 SS 2.1: TISSUE ENGINEERING Anthony Windebank, US
STRATEGIES FOR REPAIR OF
PERIPHERAL NERVE 14:15 WS 1.2: IATROGENIC
Anthony Windebank, US MONONEUROPATHIES AFTER SURGERY
AND TRAUMA
11:15 SS 2.2: USE OF PHYSICAL METHODS IN Tatjana Paternostro-Sluga, AT
NERVE REGENERATION
Thomas Hausner, AT 14:45 WS 1.3: CASE REPORT
15th International Congress on Neuromuscular Diseases WWW.ICNMD2018.ORG 15Chairs: George Padberg, NL & Nicol
13:45 - 15:15 Scientific Session SS 5.0 Voermans, NL
07 Pediatric Myology
ROOM Berg 15:45 WS 2.1: DUX4, ITS ROLE IN
DEVELOPMENT AND MUSCLE DISEASE
SATURDAY | JULY 7, 2018
Chairs: Gunther Bernert, AT & Eugenio Stephen J. Tapscott, US
Mercuri, IT
16:15 WS 2.2: TRIALS READINESS IN FSHD:
13:45 SS 5.1: STANDARDS OF CARE: WHAT CLINICAL, IMAGING AND BIOMARKERS
WE HAVE LEARNED FROM LONG TERM- Jeffrey M. Statland, US
MANAGEMENT IN CHILDREN WITH NMD'S
16:45 WS 2.3: FSHD'S CHANGING LANDSCAPE
Guenther Bernert, AT
AND FUTURE PERSPECTIVES
14:07 SS 5.2: FUTURE OF AAV-BASED GENE George Padberg, NL
THERAPY APPROACHES FOR NMDS
Thomas Voit, GB 15:45 - 17:15 Workshops WS 3.0
Palliative care in NMD
14:29 SS 5.3: NEW TREATMENTS IN PAEDIATRIC ROOM Berg
NMD'S: FAKE OR FACT?
Eugenio Mercuri, IT Chairs: David Oliver, GB & Christopher
McDermott, US
14:51 SS 5.4: TRANSITION FROM PEDIATRIC
INTO ADULT CARE: A LONG WAY TO GO? 15:45 WS 3.1: THE ROLE OF PALLIATIVE CARE
Thomas Serjensen, SE – EARLY INVOLVEMENT OR END OF LIFE
CARE?
13:45 - 15:15 Overarching Session OA 1.0 David Oliver, GB
Stem cell in neuromuscular disorders 16:07 WS 3.2: THE ROLE OF THE
ROOM Park Congress 2 MULTIDISCIPLINARY TEAM IN NMD – THE
Chairs: Zohar Argov, IL & Mayana Zatz, BR EVIDENCE FROM ALS
Christopher McDermott, US
13:45 OA 1.1: STEM CELLS AS TOOLS
FOR RESEARCH AND THERAPY IN 16:29 WS 3.3: THE RECOGNITION OF THE
NEUROMUSCULAR DISORDERS END OF LIFE PHASE IN NMD – THE
Rita Perlingeiro, US SUPPORT OF PATIENTS, FAMILIES AND
PROFESSIONALS
14:15 OA 1.2: STEM CELLS IN MUSCULAR Stefan Lorenzl, DE
DYSTROPHIES
Mayana Zatz, BR 16:51 WS 3.4: INTEGRATING PALLIATIVE CARE
INTO SERVICE FOR ALS PATIENTS: REAL-
14:45 OA 1.3: STEM CELLS IN ALS LIFE EXPERIENCE
Dimitrios Karussis, IL Lev Brylev, RU
15:15 - 15:45 NETWORKING BREAK
15:45 - 17:15 Workshops WS 4.0
ROOM Bruckner - Strauss & Klimt 2 - 3
New diagnostic techniques/tools
ROOM Park Congress 2
15:45 - 17:15 Scientific Session SS 6.0 Chairs: Anthony Amato, US & Jasper M.
Basic principles of neuromuscular Morrow, GB
involvement in cancer 15:45 WS 4.1: UPDATE ON HISTOPATHOLOGICAL
ROOM Klimt 1 FEATURES OF INFLAMMATORY
Chairs: Ahmet Hoke, US & Guido Cavaletti, MYOPATHIES
IT Anthony Amato, US
15:45 SS 6.1: GENERAL PRINCIPLES AND 16:15 WS 4.2: UPDATE ON MYOSITIS SPECIFIC
CLINICAL ASPECTS OF CIPN AUTOANTIBODIES / DISCUSSION ON
Nathan Staff, US UTILITY OF MSAS IN DIAGNOSIS AND
PROGNOSIS
16:15 SS 6.2: BASIC MECHANISMS: AXONAL Andrew Mammen, US
DEGENERATION AND CHEMOTHERAPY-
INDUCED PERIPHERAL NEUROPATHY 16:45 WS 4.3: UPDATE ON UTILITY OF
Ahmet Hoke, US SKELETAL MUSCLE MRI AND
ULTRASOUND
16:45 SS 6.3: ANIMAL MODELS OF Jasper M. Morrow, GB
CHEMOTHERAPY-INDUCED PERIPHERAL
NEUROPATHY 17:15 - 18:30 POSTER SESSION PS1
Guido Cavaletti, IT GUIDED POSTER SESSION
ROOM MEZZANINE FLOOR GALLERY
15:45 - 17:15 Workshops WS 2.0 AND FOYERS
FSHD
ROOM Park Congress 1
16 15th International Congress on Neuromuscular Diseases WWW.ICNMD2018.ORGCONGRESS PROGRAM › SUNDAY JULY 8, 2018 07
SUNDAY | JULY 8, 2018
11:29 SS 8.3: PAINFUL CRANIAL NERVE
7:00 - 8:00 INDUSTRY-SUPPORTED SEMINAR
LESIONS
ROOM BERG Frank Thömke, DE
11:51 SS 8.4: PAROXYSMAL DYSFUNCTIONS
8:00 - 10:00 Plenary Session PL 2.0 Friedrich Zimprich, AT
Neuropathy
ROOM Park Congress 1 - 2 10:45 - 12:15 Scientific Session SS 9.0
Joint ICNMD - EFAS
Chairs: Mary Reilly, GB ROOM Park Congress 3
08:00 PL 2.1: INHERITED NEUROPATHIES: FROM Chairs: Walter Struhal, AT & John D.
GENES TO CLINICAL PHENOTYPE England, US
Mary Reilly, GB
10:45 SS 9.1: PROTEINOPATHIES (THE
08:40 PL 2.2: IMMUNE MEDIATED AUTONOMIC VIEW)
NEUROPATHIES: AN EXPANDING FIELD Gregor K. Wenning, AT
OF TREATABLE NEUROPATHIES
Pieter Van Doorn, NL 11:00 SS 9.2: PROTEINOPATHIES (THE
NEUROMUSCULAR VIEW)
09:20 PL 2.3: ADVANCES IN THE TREATMENT Walter Struhal, AT
OF PERIPHERAL NEUROPATHY
David Cornblath, US 11:15 SS 9.3: HEREDITARY NEUROPATHIES (THE
AUTONOMIC VIEW)
10:00 - 10:45 NETWORKING BREAK Max Hilz, DE
ROOM BRUCKNER - STRAUSS & KLIMT
11:30 SS 9.4: HEREDITARY NEUROPATHIES (THE
2-3
NEUROMUSCULAR VIEW)
Michaela Auer-Grumbach, AT
10:45 - 12:15 Scientific Session SS 7.0 11:45 SS 9.5: METABOLIC ANS DISEASE
From bench to bedside: inherited (DIABETES AND LIVER) (THE AUTONOMIC
neuropathies VIEW)
ROOM Park Congress 1 Roy Freeman, US
Chairs: Vincent Timmerman, BE & Michael 12:00 SS 9.6: METABOLIC ANS DISEASE
Sereda, DE (DIABETES AND LIVER) (THE
NEUROMUSCULAR VIEW)
10:45 SS 7.1: NEW GENES AND NEW Paola Sandroni, US
MECHANISMS IN INHERITED
NEUROPATHIES 12:15 - 13:45 LUNCH / INDUSTRY-SUPPORTED
Vincent Timmerman, BE SEMINARS
ROOM PARK CONGRESS 1 / 2
11:15 SS 7.2: THERAPEUTIC OPTIONS IN CMT
Michael Sereda, DE
11:45 SS 7.3: FAMILIAL AMYLOID 13:45 - 15:15 Scientific Session SS 10.0
NEUROPATHIES: A TREATABLE GENETIC Diabetic neuropathies
NEUROPATHY ROOM Park Congress 3
Davide Pareyson, IT
Chairs: Eva Feldman, US & Vera Bril, CA
10:45 - 12:15 Scientific Session SS 8.0 13:45 SS 10.1: 2017 ADA POSITION STATEMENT
Cranial Nerves ON DIABETIC NEUROPATHY: DOES IT
ROOM Park Congress 2 CHANGE YOUR PRACTICE?
Vera Bril, CA
Chairs: Wolfgang Grisold, AT & Nazha
Birouk, MA 14:15 SS 10.2: SCIENTIFIC DISCOVERY LEADS
TO CLINICAL TRIALS IN DIABETIC
10:45 SS 8.1: CRANIAL NERVES: WITHIN AND NEUROPATHY
OUT OF THE SKULL, INCL. ANGIOSOMA James Russell, US
Wolfgang Grisold, AT
14:45 SS 10.3: PAINFUL DIABETIC
11:07 SS 8.2: INFECTIOUS AND INFLAMMATORY NEUROPATHY: A MANAGEMENT
CRANIAL NERVE LESIONS CENTERED APPROACH
Nazha Birouk, MA Eva Feldman, US
15th International Congress on Neuromuscular Diseases WWW.ICNMD2018.ORG 1707
SUNDAY | JULY 8, 2018
13:45 - 15:15 Workshops WS 5.0 13:45 SS 11.1: JAMES LIND ALLIANCE PRIORITY
Advances in the treatment of immune SETTING PARTNERSHIP IN NEURO-
ONCOLOGY (RESEARCH PRIORITIES)
mediated neuropathies
Kathy Oliver, GB
ROOM Park Congress 1
14:07 SS 11.2: HOW TO DO INVESTIGATOR-
Chairs: Eduardo Nobile-Orazio, IT & Jean-
INITIATED TRIALS: PCORI
Marc Léger, FR
Richard Barohn, US
13:45 WS 5.1: DIAGNOSIS AND TREATMENT OF 14:29 SS 11.3: THE PATIENT VOICE IN
CIDP: LESSON FROM THE DATABASES MYASTHENIA GRAVIS TRIALS- PCORI,
Eduardo Nobile-Orazio, IT CER, AND MORE ALPHABET SOUP
14:15 WS 5.2: PARAPROTEINEMIC Pushpa Narayanaswami, US
NEUROPATHIES: WHEN AND HOW TO 14:51 SS 11.4: HOW CAN OUTCOMES OF
TREAT CLINICAL STUDIES BE TRANSLATED FOR
Jean-Marc Léger, FR PATIENTS
Angela Genge, CA
14:45 WS 5.3: POEMS SYNDROME: FROM
DIAGNOSIS TO THERAPY
Michelle Mauermann, US 13:45 - 15:15 Overarching Session OA 2.0
Dysphagia: a neglected field in
13:45 - 15:15 Workshops WS 6.0 neuromuscular diseases
Ultrasound in cranial nerves ROOM Park Congress 2
ROOM Berg Chairs: Zohar Argov, IL
Chairs: Stefan Meng, AT & Chieh-Han Tzou, 13:45 OA 2.1: NEUROMUSCULAR DISORDERS
AT WITH DYSPHAGIA: AN OUTLINE
Marianne De Visser, NL
13:45 WS 6.1: ULTRASOUND IN CRANIAL
NERVES 14:15 OA 2.2: HOW TO ASSESS AND MANAGE
Stefan Meng, AT DYSPHAGIA
Zohar Argov, IL
14:15 WS 6.2: CLINICAL AND MICROSURGICAL
SIGNIFICANCE OF CRANIAL NERVE 14:45 OA 2.3: ETHICAL ISSUES IN DYSPHAGIA
VISUALIZATION TREATMENTS
Andres Rodriguez, SE David Oliver, GB
14:45 WS 6.3: HIGH RESOLUTION MRI OF 15:15 - 15:45 NETWORKING BREAK
CRANIAL NERVES ROOM BRUCKNER - STRAUSS & KLIMT
Jennifer Kollmer, DE 2-3
Machine in-kind donation by
15:45 - 17:15 Scientific Session SS 12.0
From bench to bedside: inflammatory
neuropathies
Note: There is a variety of different similar ROOM Park Congress 1
products that can be used beyond the ones
showcased in this session. Chairs: Hugh Willison, GB
15:45 SS 12.1: PATHOPHYSIOLOGY OF THE NODE
OF RANVIER
13:45 - 15:15 Scientific Session SS 11.0 Antonino Uncini, IT
The Patient voice
ROOM Klimt 1 16:15 SS 12.2: NEW PATHOGENETIC
MECHANISMS UNDERLYING IMMUNE
Chairs: Kathy Oliver, GB & Stefan NEUROPATHIES
Oberndorfer, AT Hugh Willison, GB
18 15th International Congress on Neuromuscular Diseases WWW.ICNMD2018.ORG07
SUNDAY | JULY 8, 2018
16:45 SS 12.3: ANTIBODIES TO THE NODE 16:30 HIV-ASSOCIATED NEUROMUSCULAR
OF RANVIER IN CIDP: A NEW CLUE TO MANIFESTATIONS: EXPERIENCE FROM
THERAPY CAPE TOWN
Luis Querol, ES Jeannine Heckmann, ZA
15:45 - 17:15 Workshops WS 7.0
15:45 - 17:15 ENMC symposium
Cachexia, myopathy and rehabilitation
ROOM Klimt 1
ROOM Berg
Chairs: George Padberg, NL & Baziel van
Chairs: Ioannis Gioulbasanis, GR & Engelen, NL
Christine Marosi, AT
15:45 WHY OPT FOR AN ENMC WORKSHOP?
15:45 WS 7.1: CACHEXIA AND LATE EFFECTS Baziel Van Engelen, NL
OF CANCER (FROM AN ONCOLOGICAL
16:00 THE IMPACT OF 25 YEARS ENMC
PERSPECTIVE)
WORKSHOPS
Ioannis Gioulbasanis, GR
Raffaella Willmann, CH
16:07 WS 7.2: SARCOPENIA 16:15 CHARCOT-MARIE-TOOTH DISEASE AT
Alan Pestronk, US ENMC WORKSHOPS
Mary Reilly, GB
16:29 WS 7.3: OUTLINE ON MYOPATHIES /
NEUROMUSCULAR COMPLICATIONS 16:30 ENMC TRANSLATIONAL RESEARCH
ASSOCIATED WITH CANCER, INCL. WORKSHOP
STEROID MYOPATHY Kanneboyina Nagaraju, US
Anthony Amato, US 16:45 AIRWAY CLEARANCE TECHNIQUES IN
NEUROMUSCULAR DISORDERS: TIPS FOR
16:51 WS 7.4: CANCER REHABILITATION A SUCCESSFUL WORKSHOP
Christine Marosi, AT Michel Toussaint, BE
17:00 THE POSITION OF NEUROMUSCULAR
15:45 - 17:15 Workshops WS 8.0
PATIENTS IN SHARED DECISION MAKING
Paraprotein in neuropathies Anna Ambrosini, IT
ROOM Park Congress 3
17:15 - 18:30 POSTER SESSION PS2
Chairs: Andreas Steck, CH & Ingemar GUIDED POSTER SESSION
Merkies, NL ROOM MEZZANINE FLOOR GALLERY
AND FOYERS
15:45 WS 8.1: SPECTRUM OF
PARAPROTEINEMIC NEUROPATHIES
Eduardo Nobile-Orazio, IT
16:15 WS 8.2: ANTI-MAG NEUROPATHY:
CURRENT AND NOVEL TREATMENTS
Andreas Steck, CH
16:45 WS 8.3: CREATING PROPER OUTCOME
MEASURES
Ingemar Merkies, NL
15:45 - 17:15 VIRTUAL MEETING
ROOM PARK CONGRESS 2
15:45 NEUROPATHIES IN AFRICA
Riadh Gouider, TN
15th International Congress on Neuromuscular Diseases WWW.ICNMD2018.ORG 1907
MONDAY | JULY 9, 2018
CONGRESS PROGRAM › MONDAY JULY 9, 2018
Chairs: Stefan Meng, AT & Udo Zifko, AT
7:00 - 8:00 INDUSTRY-SUPPORTED SEMINARS
ROOMS Klimt 1/Berg 10:45 SS 14.1: MR NEUROGRAPHY: NEW
APPROACHES AND TECHNIQUES FOR
DIAGNOSING MONONEUROPATHIES
8:00 - 10:00 Plenary Session PL 3.0 Jennifer Kollmer, DE
Motor Neurone Disease 11:15 SS 14.2: NEW ULTRASENSITIVE
ROOM Park Congress 1 - 2 ULTRASOUND METHODS
Stefan Meng, AT
Chairs: Vera Bril, CA & Claude Desnuelle,
FR 11:45 SS 14.3: OCT
Wolfgang Drexler, AT
08:00 PL 3.1: EMERGING THERAPIES FOR
MOTOR NEURONE DISEASES
Albert Ludolph, DE 10:45 - 12:15 Scientific Session SS 15.0
Pathogenesis of pain
08:40 PL 3.2: CLINICAL CONCEPT OF ALS ROOM Park Congress 3
Leonard Van Den Berg, NL
Chairs: David Bennett, US & Claudia
09:20 PL 3.3: ETHICAL ISSUES Sommer, DE
David Oliver, GB
10:45 SS 15.1: CHANGES IN THE NODAL
10:00 - 10:45 Networking Break COMPLEX IN PAINFUL NEUROPATHY
ROOM Bruckner - Strauss & Klimt 2 - 3 Claudia Sommer, DE
11:15 SS 15.2: THE USE OF NERVE
EXCITABILITY TESTING IN
10:45 - 12:15 Scientific Session SS 13.0
UNDERSTANDING ION CHANNEL
Spinal muscular atrophy (SMA) - New
DYSFUNCTION IN NEUROPATHY
treatments Matthew Kiernan, AU
ROOM Park Congress 1
11:45 SS 15.3: HUMAN PAIN
Chairs: Peter Andersen, SE & Nathalie CHANNELOPATHIES
Goemans, BE David Bennett, US
10:45 SS 13.1: OVERVIEW 12:15 - 13:45 LUNCH / INDUSTRY-SUPPORTED
Janbernd Kirschner, DE
SEMINARS
11:07 SS 13.2: TREATMENTS TO IMPROVE ROOMS Park Congress 1 / 2
SURVIVAL OF MOTOR NEURONS
Anne-Marie Hübers, DE
13:45 - 15:15 Scientific Session SS 16.0
11:29 SS 13.3: SPLICING MODIFICATION FOR
SMA
Care: Non-invasive ventilation and
Nathalie Goemans, BE nutritional aspects
ROOM Park Congress 1
11:51 SS 13.4: GENE THERAPY FOR SMA
Arthur Burghes, US Chairs: Marianne De Visser, NL & Esther
Hobson, GB
10:45 - 12:15 Scientific Session SS 14.0 13:45 SS 16.1: NIV AND ALS
Imaging in Peripheral Nerve (New Marianne De Visser, NL
Areas / New Techniques)
ROOM Park Congress 2 14:15 SS 16.2: NUTRITION AND ALS
Esther Hobson, GB
20 15th International Congress on Neuromuscular Diseases WWW.ICNMD2018.ORG07
MONDAY | JULY 9, 2018
14:45 SS 16.3: NUTRITION NIV AND COGNITION 14:15 SS 18.2: TREATMENT STRATEGIES FOR
IN ALS HEREDITARY ALS
Vincenzo Silani, IT Timothy Miller, US
13:45 - 15:15 Scientific Session SS 17.0 14:45 SS 18.3: DIAGNOSIS AND TREATMENT OF
MOTOR NEUROPATHIES
Peripheral nerve tumors
Alan Pestronk, US
ROOM Klimt 1
Chairs: Wolfgang Grisold, AT & Michelle 13:45 - 15:15 Overarching Session OA 3.0
Mauermann, US Brain involvement in muscular
disorders
13:45 SS 17.1: NEUROFIBROMATOSIS
ROOM Park Congress 2
Katharina Wimmer, AT
14:07 SS 17.2: PERIPHERAL NERVE TUMORS Chairs: Zohar Argov, IL & Corrado Angelini,
Gelareh Zadeh, CA IT
14:29 SS 17.3: INTRANEURAL PERINEURIOMA: 13:45 OA 3.1: IMPACT AND EVOLUTION OF
MAKING THE DIAGNOSIS AND CLUES TO COGNITIVE IMPAIRMENT IN MUSCULAR
THE PATHOGENESIS DYSTROPHIES
Michelle Mauermann, US Corrado Angelini, IT
14:51 SS 17.4: CANCER AND PERIPHERAL 14:15 OA 3.2: BRAIN IMAGING TECHNIQUES FOR
NERVES THE NEUROMUSCULAR PATIENTS
Wolfgang Grisold, AT Nicola De Stefano, IT
13:45 - 15:15 Workshops WS 9.0 14:45 OA 3.3: THE GAP BETWEEN COGNITIVE
Peripheral nerve surgery & ASSESSMENT AND BRAIN IMAGING:
LESSONS FROM DMD
regeneration
Erik Niks, NL
ROOM Berg
Chairs: Thomas Hausner, AT & Brian 15:15 - 15:45 Networking Break
Callaghan, US ROOM Bruckner - Strauss & Klimt 2 - 3
13:45 WS 9.1: NERVE FIBRE TRANSFER VERSUS
NERVE RECONSTRUCTION
15:45 - 17:15 Workshops WS 10.0
Robert Schmidhammer, AT
Hereditary ATTR amyloidosis and
14:15 WS 9.2: NERVE REGENERATION treatment
Ahmet Hoke, US ROOM Park Congress 2
14:45 WS 9.3: BRAIN PLASTICITY IN NERVE Chairs: Davide Pareyson, IT & Teresa
REGENERATION Coelho, PT
Thomas Hausner, AT
15:45 WS 10.1: HOW TRANSTHYRETIN
13:45 - 15:15 Scientific Session SS 18.0 BECOMES TOXIC
Laura Obici, IT
Therapeutic landscape in MND
ROOM Park Congress 3
16:15 WS 10.2: CHALLENGES IN DIAGNOSING
Chairs: Matthew Kiernan, AU & Alan AND MONITORING ATTR AMYLOIDOSIS
Pestronk, US Davide Pareyson, IT
13:45 SS 18.1: MND: THERAPEUTIC 16:45 WS 10.3: THE NOVEL SCENARIO OF ATTR
LANDSCAPES AMYLOIDOSIS TREATMENT
Matthew Kiernan, AU Teresa Coelho, PT
15th International Congress on Neuromuscular Diseases WWW.ICNMD2018.ORG 2107
MONDAY | JULY 9, 2018
15:45 - 17:15 Workshops WS 11.0 15:45 - 17:15 Workshops WS 13.0
Vitamin deficiencies Neoplastic neuromuscular
ROOM Park Congress 3 involvement
ROOM Berg
Chairs: Steven Lewis, US & Nathan Staff,
US Chairs: Wolfgang Grisold, AT & P. James
Dyck, US
15:45 WS 11.1: VITAMIN DEFICIENCIES AND
NEUROPATHY 15:45 WS 13.1: CRANIAL NERVES
Carrie Grouse, US Wolfgang Grisold, AT
16:15 WS 11.2: MINERAL DEFICIENCIES AND 16:15 WS 13.2: PERIPHERAL NERVE LYMPHOMA
NEUROPATHY P. James Dyck, US
Steven Lewis, US
16:45 WS 13.3: CANCER-ASSOCIATED MYOSITIS
16:45 WS 11.3: VITAMIN AND MINERAL Yves Allenbach, FR
TOXICITIES AND NEUROPATHY
Nathan Staff, US 17:15 - 18:30 Poster Session PS3
Guided Poster Session
15:45 - 17:15 Scientific Session SS 19.0 ROOM Mezzanine Floor Gallery and
Distal SMA Foyers
ROOM Park Congress 1
Chairs: Wolfgang Löscher, AT
15:45 SS 19.1: DISTAL HEREDITARY MOTOR
NEUROPATHIES (DHMN)
Mary Reilly, GB
16:15 SS 19.2: DISTAL MYOPATHIES
Anthony Amato, US
16:45 SS 19.3: ACQUIRED DISTAL MOTOR
SYNDROMES
Matthew Kiernan, AU
15:45 - 17:15 Workshops WS 12.0
Rehabilitation in ALS
ROOM Klimt 1
Chairs: Orla Hardiman, IE & Dana Boering,
DE
15:45 WS 12.1: MULTIDISCIPLINARY CLINICS-
WHAT IS THE EVIDENCE AND HOW CAN
WE DO BETTER?
Leonard Van Den Berg, NL
16:15 WS 12.2: MEASUREMENT OF DISEASE
PROGRESSION, CAN WE DO BETTER?
Orla Hardiman, IE
16:45 WS 12.3: REHABILITATION
INTERVENTIONS THAT CHANGE
OUTCOME IN ALS/MND
Dana Boering, DE
22 15th International Congress on Neuromuscular Diseases WWW.ICNMD2018.ORGCONGRESS PROGRAM › TUESDAY JULY 10, 2018 07
TUESDAY | JULY 10, 2018
8:00 - 10:00 Plenary Session PL 4.0 10:45 - 12:15 Scientific Session SS 22.0
Neuromuscular Junction History
ROOM Park Congress 1 - 2 ROOM Park Congress 3
Chairs: Julia Wanschitz, AT & Juan Jesús Chairs: Sonja Horn, AT & Raad Shakir, GB
Vílchez Padilla, ES
10:45 SS 22.1: THE HISTORY OF
08:00 PL 4.1: PHYSIOLOGY AND STRUCTURE NEUROMUSCULAR DISEASES AND THEIR
Steve Burden, US TREATMENT IN HABSBURG COUNTRIES
08:40 PL 4.2: CONGENITAL MYASTHENIC Sonja Horn, AT
SYNDROMES - NEW GENES AND BETTER
11:15 SS 22.2: HISTORY ON NM DISEASE
TREATMENTS / ANTIBODIES
Richard Barohn, US
Kinji Ohno, JP
09:20 PL 4.3: AUTOIMMUNITY 11:45 SS 22.3: ANDALUSIAN NEUROLOGY OVER
Angela Vincent, GB 700 YEARS
Raad Shakir, GB
10:00 - 10:45 NETWORKING BREAK
ROOMS BRUCKNER - STRAUSS & KLIMT 12:15 - 13:45 LUNCH / INDUSTRY-SUPPORTED
2-3 SEMINARS
ROOMS PARK CONGRESS 1 / 2
10:45 - 12:15 Scientific Session SS 20.0
New therapies in myasthenia - clinical 13:45 - 15:15 Scientific Session SS 23.0
session Issues regarding thymectomy in
ROOM Park Congress 1 myasthenia
ROOM Park Congress 1
Chairs: Gil Wolfe, US & Wolfgang Löscher,
AT Chairs: Richard Barohn, US & Alexander
Marx, DE
10:45 SS 20.1: EVOLUTION OF MONOCLONAL AB
TREATMENT APPROACHES IN MG 13:45 SS 23.1: THYMECTOMY FOR MYASTHENIA
Gil Wolfe, US GRAVIS
11:15 SS 20.2: OTHER NOVEL TREATMENT Richard Barohn, US
APPROACHES: EXERCISE
14:15 SS 23.2: RANDOMIZED CONTROLLED
Anna Punga, SE
TRIAL OF THYMECTOMY: A DEEPER DIVE
11:45 SS 20.3: OVERVIEW OF TREATMENT INTO DATA
GUIDELINES: GOING FORWARD Gil Wolfe, US
Gil Wolfe, US
14:45 SS 23.3: PATHOLOGY OF THE THYMUS
GLAND IN MG
10:45 - 12:15 Scientific Session SS 21.0
Alexander Marx, DE
Infectious neuropathies
ROOM Park Congress 2
13:45 - 15:15 Workshops WS 14.0
Chairs: John D. England, US & Gerard Said, Discussion on novel treatments and
FR their mechanisms in different forms of
NMJ disorders
10:45 SS 21.1: NEUROLOGICAL COMPLICATIONS
OF ZIKA VIRUS ROOM Park Congress 2
John D. England, US
Chairs: Markus Rüegg, CH & David Beeson,
11:07 SS 21.2: LEPROUS NEUROPATHIES GB
Gerard Said, FR
13:45 WS 14.1: MOLECULAR MECHANISMS
11:29 SS 21.3: NEUROPATHIES IN INFECTIOUS AFFECTING NEUROMUSCULAR JUNCTION
DISEASES DEVELOPMENT AND MAINTENANCE
Nazha Birouk, MA Markus Rüegg, CH
11:51 SS 21.4: INFECTION RELATED 14:15 WS 14.2: SALBUTAMOL AND DOK-7 AS
NEUROMUSCULAR DISORDERS POTENTIAL TREATMENT OPTIONS FOR
(NEUROPATHIES AND MYOPATHIES) NEUROMUSCULAR DISORDERS
Chandrashekhar Meshram, IN David Beeson, GB
15th International Congress on Neuromuscular Diseases WWW.ICNMD2018.ORG 2307
TUESDAY | JULY 10, 2018
14:45 WS 14.3: SYMPATHETIC INNERVATION
OF THE NMJ; A POSSIBLE EXPLANATION 13:45 - 15:15 Workshops WS 17.0
FOR THE THERAPEUTIC EFFECT OF Miscellaneous diseases
SYMPATHICOMIMETICS IN NMDS? ROOM Klimt 1
Rüdiger Rudolf, DE
Chairs: Andreas Steck, CH & Hadi Manji, GB
13:45 - 15:15 Workshops WS 15.0
Plectin & Plectinopathies: roots & 13:45 WS 17.1: PRIMARY AND SECONDARY
perspectives VASCULITIC NEUROPATHY
ROOM Berg Gerard Said, FR
Chairs: Rolf Schröder, DE & Gerhard Wiche, 14:15 WS 17.2: STATIN NEUROPATHIES
AT Hadi Manji, GB
13:45 WS 15.1: PLECTIN: OVERVIEW AND
14:45 WS 17.3: MGUS ASSOCIATED
LESSONS FROM MOUSE MODELS
PERIPHERAL NEUROPATHY: DIAGNOSIS
Gerhard Wiche, AT
AND TREATMENT
Andreas Steck, CH
14:07 WS 15.2: HUMAN PLECTIN AND CLINICAL
ASPECTS
Rolf Schröder, DE 15:15 - 15:45 NETWORKING BREAK
ROOMS BRUCKNER - STRAUSS & KLIMT
14:29 WS 15.3: PLECTIN AND MITOCHONDRIA
(MICE AND MEN) 2-3
Lilli Winter, AT
14:51 WS 15.4: PLECTIN, CARDIOMYOPATHIES, 15:45 - 17:15 Scientific Session SS 24.0
AND THERAPEUTIC APPROACHES (MICE) Congenital Myasthenic Syndrome
Oliver Mueller, DE (CMS)
ROOM Park Congress 1
13:45 - 15:15 Workshops WS 16.0
LGMD symposium Chairs: David Beeson, GB & Friedrich
ROOM Park Congress 3 Zimprich, AT
Chairs: Corrado Angelini, IT & Kristl Claeys,
15:45 SS 24.1: SYNAPTIC STABILITY IN CMS
BE
David Beeson, GB
13:45 WS 16.1: THE CLINICAL PHENOTYPES OF
CALPAINOPATHY 16:07 SS 24.2: RECENT PROGRESS IN
Andoni Urtizberea, FR UNDERSTANDING PRESYNAPTIC
CONGENITAL MYASTHENIC SYNDROMES
14:07 WS 16.2: MUSCLE PATHOLOGY OF LIMB- (CMS)
GIRDLE MUSCULAR DYSTROPHIES Hanns Lochmüller, DE
(LGMD)
Kristl Claeys, BE 16:29 SS 24.3: CLINICAL ASPECTS OF CMS
Hakan Cetin, AT
14:29 WS 16.3: THE ADVENT OF NGS IN LGMD
DIAGNOSIS
16:51 SS 24.4: THERAPEUTIC STRATEGIES FOR
Vincenzo Nigro, IT
CONGENITAL MYASTHENIC SYNDROMES
14:51 WS 16.4: PERSPECTIVES IN CLINICAL Jacqueline Palace, GB
TRIALS OF RECESSIVE AND DOMINANT
LGMD
Corrado Angelini, IT
24 15th International Congress on Neuromuscular Diseases WWW.ICNMD2018.ORG07
TUESDAY | JULY 10, 2018
15:45 - 17:15 Workshops WS 18.0 15:45 - 17:15 Workshops WS 20.0
Biomarkers in myasthenia gravis Aspects of diabetes
ROOM Park Congress 2 ROOM Klimt 1
Chairs: Nils Erik Gilhus, NO & Anna Punga, Chairs: Eva Feldman US & Brian
SE Christopher Callaghan, US
15:45 WS 18.1: AUTOANTIBODIES IN 15:45 WS 20.1: DIABETIC CRANIAL
MYASTHENIA GRAVIS NEUROPATHIES
Nils Erik Gilhus, NO Tudor Lupescu, RO
16:15 WS 18.2: CIRCULATING MICRO-RNA AS 16:07 WS 20.2: MUSCULOSKELETAL
BIOMARKERS IN MYASTHENIA GRAVIS COMPLICATIONS OF DIABETES ARE
Anna Punga, SE COMMON AND UNDERDIAGNOSED
16:45 WS 18.3: THYMUS BIOMARKERS AND Anna Grisold, AT
CLINICAL RELEVANCE 16:29 WS 20.3: ATYPICAL NEUROPATHIES
Alexander Marx, DE IN DIABETES: DIAGNOSIS AND
MANAGEMENT
15:45 - 17:15 Workshops WS 19.0 Amanda Peltier, US
Muscle and nerve biopsies for
neurologist 16:51 WS 20.4: TREATMENT INDUCED AND
INFLAMMATORY NEUROPATHIES IN
ROOM Park Congress 3
DIABETES
Chairs: Rolf Schröder, DE & Monika Hofer, Brian Christopher Callaghan, US
GB
17:15 - 18:15 CLOSING CEREMONY
15:45 WS 19.1: MUSCLE BIOPSIES ROOM PARK CONGRESS 1 – 2
Rolf Schröder, DE
16:15 WS 19.2: NERVE BIOPSIES: THERE IS
STILL A PLACE FOR NERVE BIOPSY IN
MODERN CLINICAL PRACTICE
P. James Dyck, US
16:45 WS 19.3: SKIN BIOPSIES
Giuseppe Lauria, IT
15th International Congress on Neuromuscular Diseases WWW.ICNMD2018.ORG 2526 15th International Congress on Neuromuscular Diseases WWW.ICNMD2018.ORG
08
CONGRESS INFORMATION
Congress
Information
15th International Congress on Neuromuscular Diseases WWW.ICNMD2018.ORG 2708 FLOORPLAN › Hilton Vienna
CONGRESS INFORMATION
GROUND FLOOR
GROUND FLOOR
28 15th International Congress on Neuromuscular Diseases WWW.ICNMD2018.ORG08
CONGRESS INFORMATION
MEZZANINE FLOOR
KLIMT 1
KLIMT 2+3
Breakout Room Meeting Rooms
Plenary Hall Board Room
Speaker Ready Room Exhibition & Poster Area
15th International Congress on Neuromuscular Diseases WWW.ICNMD2018.ORG 2908
CONGRESS INFORMATION
GENERAL INFORMATION FROM A-Z
CAMERAS AND CELL PHONES Snacks and Lunch
No video cameras are allowed at any event during ICNMD Luncheon industry-supported seminars are offering
2018. As a courtesy to fellow attendees, please turn off lunch. During lunch time light snacks will also be offered
cell phones during scientific sessions. within the exhibition and poster area.
CATERING ONSITE CERTIFICATE OF ATTENDANCE
Networking Breaks To complete the session evaluation and obtain credits for
your attendance at ICNMD 2018, please use the online
Networking breaks will take place from Friday 6 to Tues- evaluation link provided via email on the last day of the
day 10 July in the Exhibition & Poster Area, located on the Congress.
Mezzanine Floor.
CHARGING LOUNGE
FRIDAY, JULY 6 Charging stations will be available in the Exhibit Hall
(Rooms Bruckner - Strauss ) to allow you to take a break
09.50 – 10.10 AND 12.00-13.00 AND 14:50-15:10 while powering your mobile devices.
SATURDAY, JULY 7 – TUESDAY, JULY 10 Supported by
10.00-10:30 AND 12:30 – 13:30 AND 15:15-15:45
30 15th International Congress on Neuromuscular Diseases WWW.ICNMD2018.ORG08
CONGRESS INFORMATION
CLOAK ROOM DELEGATE HELP DESK
The cloak room is located within the bag distribution area If you require assistance or any information regarding the
in the Park Congress Foyer Area on the Ground Floor. Congress, see the staff at the Delegate Help Desk located
in the registration area.
CME CREDIT ALLOWANCE
Supported by
The 15th International Congress on Neuromuscular Dis-
eases (ICNMD 2018) is accredited by the European Accred-
itation Council for Continuing Medical Education (EAC-
CME) to provide the following CME activity for medical
specialists. The EACCME is an institution of the European DELEGATE LOUNGES
Union of Medical Specialists (UEMS), www.uems.net.
Delegate Lounges are available in the Exhibit Hall (Klimt
2+3) to allow you to take a break, network with colleagues
ICNMD 2018 will be accredited with 34 European CME or check emails.
credits (ECMEC) by the European Accreditation Council for
Continuing Medical Education (EACCME). Supported by
Through an agreement between the European Union of
Medical Specialists and the American Medical Asso-
ciation, physicians may convert EACCME credits to an
equivalent number of AMA PRA Category 1 Credits™.
Information on the process to convert EACCME credit to
AMA credit can be found at www.ama-assn.org/go/ inter-
nationalcme.
15th International Congress on Neuromuscular Diseases WWW.ICNMD2018.ORG 31You can also read
